| Prostanoid |
| LIPID_ID | PR0064 |
| CHEM_NA | 7-[2(R)-(3(S),7-DIHYDROXY-1(E)-OCTENYL)-5-OX |
| O-3-CYCLOPENTEN-1(R)-YL]-5(Z)-HEPTENOIC |
| ACID/(15(S),19-DIHYDROXY-9-OXO-8(12),13-TRAN |
| S-PROSTADIENOIC ACID) |
| COMMON_NA | 19-HYDROXY-PROSTAGLANDIN A2 |
| MOL_FORMULA | C20H30O4 |
| MOL_WT | 350 |
| MELT_PT |
| BOIL_PT |
| OPT_ROT |
| REFRA_IND |
| DENSITY |
| SOLUBILITY | ETHYL ETHER, CHLOROFORM, ETHANOL(169) |
| UV_SPEC | λMAX EtOH 217 nm(ε= 〜10,000) (169) |
| IR_SPEC | 5.87, 6.30, 10.3μ (169) |
| NMR_SPEC | 1H-NMR: δ 5.75-5.50(m,2H,13,14-CH), |
| 5.50-5.25(m,2H,5,6-CH),1.15(d,3H,20-CH) (169) |
| MS_SPEC | METHYL ESTER : M/E 364(M+), 246, 328, 315 (169) |
| NOTE_SPEC |
| SOURCE | ヒト精液中に存在する(153)｡ |
| 19-HYDROXY-PGE2より生じた人為産物とされている( |
| BIOL_ACTIV | ヒト子宮筋収縮を阻害する(161)｡ |
| NOTE |
| 1998年7月17日 | 36 / 70 ページ |